Amy Calistri
Stock of the Month
Stephen Leeb
Income Performance Report
Roger Conrad
The Utility Forecaster
Paul McWilliams
Next Inning

Taiwan: Invest in the 'other China'


Bookmark and Share

 "Taiwan - the so-called 'other China' - is an overlooked gem," says Martin Hutchinson, contributing editor to the top-notch Money Morning.

"With a per capita income of nearly $30,000, and a productivity growth rate of 4% -- more than double the rates enjoyed by Europe and the United States -- Taiwan is one of the world’s best bargains." Here, the advisor looks at a trio of ways to invest in Taiwan.

"There’s no question that the Taiwanese economy is highly dependent on China. Indeed, fully 38% of Taiwan’s exports go to China - including Hong Kong - while 16% of Taiwan’s imports originate on the mainland."

"Some of Taiwan’s most important companies do a great deal of their manufacturing in China, since labor costs are lower there. Essentially, the intellectual input comes from Taiwan’s superb education system and highly competitive tech sector, while China provides the skilled labor at low cost.

Advertisement
Banner

"Taiwan’s inflation rate is a paltry 3%, government spending accounts for a mere 21% of the country’s economic activity and the country runs a hefty balance-of-payments surplus. Unlike China, there are no signs of major problems in Taiwan’s banking system.

"Thus, even though Taiwan’s growth rate is lower than China’s 'official' growth rate, the greater stability of Taiwan’s economy ought to make the shares of Taiwan-based companies trade at a premium to those based in China.

"Unfortunately, that’s not the case. Instead, Taipei trades at less than half the earnings multiple of Shanghai, and the Taiwan stock market failed to participate in the rapid 2007 run-up seen by stock markets in China and several other Asian countries.

"If the relations between China and Taiwan improve enough under the newly elected Kuomintang government to cause the economic dealings between the two countries to accelerate, Taiwan could see a nice run-up in its stock prices - even if the other Asian markets are rather dull this year.

"One highly effective way to play the Taiwan market is with the iShares MSCI Taiwan Index (ASE: EWT), an exchange-traded fund that’s currently trading at only 13 times earnings and yielding a worthwhile 2.6%.

"Taiwan Semiconductor (NYSE: TSM), trading at 15 times earnings and yielding 4%, is the top Taiwan blue-chip stock. It’s the world’s largest semiconductor fabricator, producing approximately 7.15 million wafers in 2006, distributing its products in the United States, Europe, Japan, China, Korea and India, among others.

"You might also look at Siliconware Precision Industries (NASDAQ: SPIL), which yields a substantive 4.8%, and is trading on only 8.4 times projected 2008 earnings. These valuations are well below those available in slow-growing Western markets, let alone in China."

Editor's note: For serious investors seeking a first-hand look at the China region, Money Morning co-editor Keith Fitz-Gerald, will be hosting an in-depth investor tour to China from April 15-30, 2008. The trip will cover Beijing, Xian, a Yangtze River Cruise, Shanghai, and Hong Kong. For more information, please click here.

 


Banner
News Flash

Linkedin: Professional profits
by Leo Fasciocco, editor Ticker Tape Digest

Online professional network operator Linkedin (LNKD) recently moved above its technical breakout point of $108.53. We now target a move to $138.


Read more...

 

Tap in to water stocks
by Doug Fabian, editor Making Money Alert

As we prepare for the summer heat, water presents a significant investment opportunity -- especially as states such as California and Texas face droughts. The PowerShares Water Resource ETF (PHO) presents one way to invest in water's untapped potential.


Read more...


   

Pax World: High yield exception
by Amy Calistri, editor The Daily Paycheck

I generally prefer closed-end or exchange-traded funds because the fees tend to be lower. But I made a special case for Pax World High Yield Bond (PAXHX); this high-yield bond fund is my only open-ended mutual fund holding.


Read more...

 

Amgen: Biotech DRIP
by Chuck Carlson, editor DRIP Investor

Amgen (AMGN) is one of the oldest and largest players in the biotechnology area. It pioneered the development of products based on advances in recombinant DNA and molecular biology, launching the biotechnology industry’s first blockbuster medicines.


Read more...

 

Fidelity fund expert looks to Japan
by Jim Lowell, editor Fidelity Investor

In my May Marketwatch investment strategy column I noted, “Set against the backdrop of having already been thrown out with the Eurozone’s bathwater, I like Japan’s marketplace overall and, more specifically, their small cap marketplace which caters to domestic counter traffic.”


Read more...

 

MOO: Market Vectors Agribusiness
by Doug Fabian, editor Making Money Alert

Everyone needs food to survive, so wouldn't it be great to make money from it? We can. The global agriculture business provides a fairly stable investment with growth potential. In particular, I am looking at Market Vectors Agribusiness ETF (MOO).


Read more...

 

Celgene: Selloff creates opportunity
by J. Royden Ward, editor Cabot Benjamin Graham Value Letter

Celgene (CELG) develops and assists in the marketing of drugs to treat cancer and infl ammatory diseases. It acquired several companies recently, which will expand its product line and add promising products in various stages of development.


Read more...

 

Senior housing reits for income
by Brian Hicks, editor Wealth Advisory

Omega Healthcare Investors (OHI) and Medical Properties Trust (MPW) caters to the senior housing/assisted living facilities. Given the growing senior population, it makes sense to be somewhat over-exposed to companies that target this market.


Read more...

 

Buffett: Still banking on banks
by Ron Rowland, editor All Star Investor

Wise investors zero in on conflicting data points. Warren Buffett, the wisest investor of all, provided plenty to consider at the Berkshire Hathaway annual meeting. 


Read more...

 

Questcor: 'Exponential demand'
by Dennis Slothower, editor Stealth Stocks

Questcor Pharmaceuticals (QCOR), our latest featured stock of the month, is a biopharmaceutical company whose primary product helps patients with serious, difficult-to-treat medical conditions.


Read more...

 



Banner



Close
Select Offer: Schwab Options Market Commentary